Announced Tue, 27 May · 18:45 IST

Submission of intimation of appointment of secretarial auditor of the company.

Management Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Novelix Pharmaceuticals Ltd (formerly Trimurthi Limited) has appointed M/s Khushbu Kanwar & Co., Practicing Company Secretaries based in Jaipur, as its Secretarial Auditor. The appointment is for a period of five years, from April 1, 2025 to March 31, 2030, and is subject to shareholder approval at the upcoming Annual General Meeting. The decision was taken at the Board meeting held on May 27, 2025. The firm is not related to any directors or key managerial personnel of the company. This appointment is made in compliance with Section 204 of the Companies Act, 2013 and SEBI Listing Regulations.

Likely market impact

This is a routine regulatory compliance filing required for all listed companies and is unlikely to have any material impact on the stock price or shareholder value. Shareholders will get a chance to vote on this appointment at the next AGM.